Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Jointly discovered KAT6i molecule originating from Australian research has initiated Phase 3 in HR+ HER2- Breast Cancer with Pfizer Inc 2025-09-15 12:06
MGI Tech Introduces DNBSEQ-T7+: A Next-Generation 'Data Mining Machine' for Genomics 2025-09-15 11:53
Lion TCR Achieves Triple FDA Milestones with IND Clearance for Chronic Hepatitis B Following Earlier Fast Track and Orphan Drug Designations 2025-09-15 08:00
Real-World Evidence of NEFECON® to Be Presented in Seven New Abstracts at the 18th International lgAN Symposium 2025-09-15 07:45
/C O R R E C T I O N -- Mars/ 2025-09-13 06:14
Indication Expansion Accelerates: First Patient Dosed in Melanoma Phase 1b/II Trial of Opamtistomig 2025-09-12 12:39
The New Drug Application for KN026 (Anbenitamab Injection) Has Been Accepted by the National Medical Products Administration 2025-09-12 09:51
GLOBAL FIRST "High-Definition Image": Decoding the "Code of Youth" - LivingPhoenix's POGMENT Collagen Breakthrough Bridges International Gap 2025-09-11 20:26
Lundbeck showcases new clinical migraine data, including long-term preventive effectiveness of Vyepti® (eptinezumab) in patients severely impacted by migraine 2025-09-11 14:56
HaemaLogiX wins "Most Promising CAR-T Pipeline in APAC" at the Asia Pacific CGT¹ Excellence Awards 2025 2025-09-11 11:52
Amaran Biotech Wins Asia-Pacific Biologics CDMO Excellence Award for "Best Fill-Finish" 2025-09-11 10:00
XingImaging in partnership with SynuSight was awarded a grant from The Michael J. Fox Foundation to support development of the α-synuclein PET tracer 18F-FD4 for Parkinson's disease 2025-09-11 05:06
Telix Doses First Patient in Phase 3 BiPASS Trial: PSMA-PET Imaging for Prostate Cancer Diagnosis 2025-09-10 07:01
XtalPi AI Drug Discovery Collaboration Reaches Milestone as PharmaEngine's Novel PRMT5 Inhibitor PEP08 Receives Clinical Trial Approvals 2025-09-09 20:42
Amorepacific Group Marks 80th Anniversary: Unveils New Vision Slogan "Create New Beauty" 2025-09-09 09:00
Servier acquires potential treatment for Fragile X syndrome, the most common genetic cause of autism spectrum disorder 2025-09-08 15:49
Huadong Medicine Announces Positive Preliminary Results from a Phase Ⅰ study of HDM2005, a ROR1-Targeting ADC 2025-09-05 21:38
FUTUONING Sets Sail Commercially with First Prescriptions Across China 2025-09-05 18:12
NYSE Content Advisory: Pre-Market Update + Biotech Enveda raises $150 million to reach unicorn status 2025-09-04 21:06
Halia Therapeutics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference 2025-09-04 20:00
1 8 9 10 11 12 263